Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on UK Healthcare Gazette.
Press releases published on June 25, 2025
Ethnic Food Global Market Projections Reach $97.34 Billion By 2029
EIN Presswire
·
June 25, 2025
The Business Research Company’s Ethnic Food Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 25, 2025 /EINPresswire.com/ -- The ethnic food market, brimming with diversity and cultural …
Fats And Oils Global Market Forecast To 2034 – For Business Leaders, Analysts, And Strategic Teams
EIN Presswire
·
June 25, 2025
The Business Research Company’s Fats And Oils Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 25, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The Fats And Oils Market? …
Global Flow Cytometry Market To Reach $11.6 Billion By 2029 With A Growth Rate Of 11.5%
EIN Presswire
·
June 25, 2025
The Business Research Company’s Flow Cytometry Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 25, 2025 /EINPresswire.com/ -- The flow cytometry market has witnessed substantial growth …
Key Trend Shaping The Food Allergen Testing Market In 2025: New Rapid Gluten Test Promises Accurate Detection
EIN Presswire
·
June 25, 2025
The Business Research Company’s Food Allergen Testing Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 25, 2025 /EINPresswire.com/ -- What Is The Growth Trajectory Of The Food Allergen …
Altin Biosciences announces US patent approval for its first-in-class, non-hormonal, oral botanical drug candidate.
EIN Presswire
·
June 25, 2025
A non-surgical, non-hormonal drug that is easy to take, easy to tolerate, and preserves fertility is exactly what patients and doctors have demanded for years. EMERYVILLE, CA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Non-hormonal oral …
Amniotic Membrane Market Poised for Steady Growth, Reaching $1.7 Billion by 2030
EIN Presswire
·
June 25, 2025
PORTLAND, OR, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The global amniotic membrane market is experiencing a consistent upward trend, driven by advancements in regenerative medicine, growing awareness about wound care, and increasing ophthalmic …
Blue Goat Cyber Launches Milestone 25th Podcast Episode: Cybersecurity Labeling and MedTech Transparency
EIN Presswire
·
June 25, 2025
The industry’s most trusted podcast hits a major milestone with a deep dive into labeling, trust, and the future of global medical device cybersecurity. SCOTTSDALE, AZ, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- Blue Goat Cyber, the global …
Sara Davies MBE Leads Empowering New Campaign for DB Wider Fit Shoes Celebrating Women at Every Life Stage
EIN Presswire
·
June 25, 2025
Joyful Strides: Embracing Your Best Decade” puts foot health, style and confidence centre stage — with powerful stories from real women BEDFORDSHIRE, UNITED KINGDOM, June 25, 2025 /EINPresswire.com/ -- Wednesday 25th June 2025, Bedfordshire, UK – What …
Sam Sammane on 95% AI Adoption in Life Sciences; TheoSym Ready to Support the Industry’s Next Big Transition
EIN Presswire
·
June 25, 2025
AI adoption in life sciences hits 95%. Sam Sammane says it’s a turning point—and TheoSym is ready to support the shift with trusted validation. IRVINE, CA, UNITED STATES, June 24, 2025 /EINPresswire.com/ -- A recent landmark report by Rockwell …
DBal Max Introduces Legal Dianabol Pills for Muscle Growth: A Safe Steroid Now Available in USA
GlobeNewswire
·
June 25, 2025
London, UK, June 25, 2025 (GLOBE NEWSWIRE) -- In a landmark move set to redefine the muscle-building supplement industry, DBal Max today announced the official launch of its legal Dianabol pills in the USA—a scientifically-formulated, safe alternative to …
Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
GlobeNewswire
·
June 25, 2025
June 25, 2025 Biodexa Announces Activation of First Clinical Study Site for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company …
Vascular Closure Devices Market to Reach USD 2.07 Billion by 2035, Registering 7.3% CAGR
EIN Presswire
·
June 25, 2025
Analysis of Vascular Closure Devices Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea MD, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- The global vascular closure devices …
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director
GlobeNewswire
·
June 25, 2025
Essential Pharma strengthens Board with the appointment of Nicola Heffron as Non-Executive Director Egham, UK – 25 June 2025 – Essential Pharma (“Essential” or “the Company”), a global pharmaceutical company developing and delivering medicines for patients …
Actimed Therapeutics Enrolls First Patients in Phase 2a PROACT Study Programme to Assess S-pindolol benzoate in Obese Patients During and Post-GLP-1 Agonist Therapy
GlobeNewswire
·
June 25, 2025
Two-part clinical study programme to evaluate change in lean and fat mass in patients receiving two different doses of S-pindolol benzoate whilst 1) receiving the GLP-1 agonist semaglutide; and 2) after cessation of semaglutide treatment Initial proof-of- …